Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emanuela Dell’Aquila, Grazia Armento, Michele Iuliani, Sonia Simonetti, Loretta D’Onofrio, Tea Zeppola, Cristina Madaudo, Marco Russano, Fabrizio Citarella, Giulia Ribelli, Francesco Pantano, Bruno Vincenzi, Giuseppe Tonini & Daniele Santini. (2020) Denosumab for cancer-related bone loss. Expert Opinion on Biological Therapy 20:11, pages 1261-1274.
Read now
Read now
Ewelina Jagiello-Wieczorek, Andrzej Pieńkowski & Piotr Rutkowski. (2015) Denosumab for treating giant cell tumor of bone. Expert Opinion on Orphan Drugs 3:10, pages 1219-1229.
Read now
Read now
Lizz van der Heijden, Michiel A J van de Sande, Pancras C W Hogendoorn, Hans Gelderblom & P D Sander Dijkstra. (2015) Neoadjuvant denosumab for extensive giant cell tumor in os ischium —a case report. Acta Orthopaedica 86:3, pages 393-395.
Read now
Read now
Articles from other publishers (34)
Noureldin Mohamed AbdelKawi, Yasser Youssef Abed, Abed Abdelatif El-negery & Samir Zaki Mohamed Kotb. (2023) Risk factors for local recurrence of giant cell tumor of bone of the extremities: a retrospective study. Current Orthopaedic Practice 34:1, pages 16-21.
Crossref
Crossref
Liming Zhao, Jiapei Chen, Yongcheng Hu, Zhaoming Ye & Kun Tao. (2022) Mid-term results of giant cell tumours with pathologic fractures around the knee: a multicentre retrospective study. BMC Musculoskeletal Disorders 23:1.
Crossref
Crossref
J. Maximen, R. Delacroix & M. Ropars. (2022) Tumores óseos benignos metafisoepifisarios. EMC - Técnicas Quirúrgicas - Ortopedia y Traumatología 14:4, pages 1-13.
Crossref
Crossref
Selami KARADENİZ, Alparslan YURTBAY, Furkan ERDOĞAN, İsmail BÜYÜKCERAN & Nevzat DABAK. (2022) Giant cell tumor of the bone: an evaluation of prognostic factors associated with local recurrence and a comparison with the current literature. Anatolian Current Medical Journal 4:4, pages 349-355.
Crossref
Crossref
I Gede Eka Wiratnaya, I Wayan Subawa, Putu Astawa & Hans Kristian Nugraha. (2021) Arthroscopic Management of Giant Cell Tumor of the Calcaneus. Foot & Ankle Specialist 15:3, pages 266-271.
Crossref
Crossref
J. Maximen, R. Delacroix & M. Ropars. (2022) Tumori ossei benigni metafisoepifisari. EMC - Tecniche Chirurgiche - Chirurgia Ortopedica 18:2, pages 1-14.
Crossref
Crossref
Yushan Wang, Qiaoqiao Tian, Chenyang Wu, Haoze Li, Jian Li & Yi Feng. (2021) Management of the Cavity After Removal of Giant Cell Tumor of the Bone. Frontiers in Surgery 8.
Crossref
Crossref
Jin Ke, Shi Cheng, Meng‐yu Yao, Xiao Chu, Ming Wang, Xiao‐long Zeng, Tao Yang, Chi Zhang, Hua Zhong & Yu Zhang. (2021) Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study. Orthopaedic Surgery 13:1, pages 185-195.
Crossref
Crossref
Daniel T. Miles, Ryan T. Voskuil, Wood Dale, Joel L. Mayerson & Thomas J. Scharschmidt. (2020) Integration of denosumab therapy in the management of giant cell tumors of bone. Journal of Orthopaedics 22, pages 38-47.
Crossref
Crossref
Yongzhao Zhao, Xiaodong Tang, Taiqiang Yan, Tao Ji, Rongli Yang & Wei Guo. (2020) Risk factors for the local recurrence of giant cell tumours of the sacrum treated with nerve-sparing surgery. The Bone & Joint Journal 102-B:10, pages 1392-1398.
Crossref
Crossref
Jonathan Lans, Kamil Oflazoglu, Hang Lee, Neil G. Harness, René M. Castelein, Neal C. Chen & Santiago A. Lozano Calderón. (2020) Giant Cell Tumors of the Upper Extremity: Predictors of Recurrence. The Journal of Hand Surgery 45:8, pages 738-745.
Crossref
Crossref
Obada Hasan, Moiz Ali, Mohammad Mustafa, Arif Ali & Masood Umer. (2019) Treatment and recurrence of giant cell tumors of bone – A retrospective cohort from a developing country. Annals of Medicine and Surgery 48, pages 29-34.
Crossref
Crossref
Costantino Errani, Shinji Tsukamoto, Giovanni Ciani & Davide Maria Donati. (2019) Present day controversies and consensus in curettage for giant cell tumor of bone. Journal of Clinical Orthopaedics and Trauma 10:6, pages 1015-1020.
Crossref
Crossref
Astrid Lipplaa, Judith R. Kroep, Lizz van der Heijden, Paul C. Jutte, Pancras C.W. Hogendoorn, Sander Dijkstra & Hans Gelderblom. (2019) Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial. The Oncologist 24:7, pages 889-e421.
Crossref
Crossref
Astrid Lipplaa, Sander Dijkstra & Hans Gelderblom. (2019) Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone. Current Opinion in Oncology 31:4, pages 329-335.
Crossref
Crossref
Changye Zou, Tiao Lin, Bo Wang, Zhiqiang Zhao, Bin Li, Xianbiao Xie, Gang Huang, Junqiang Yin & Jingnan Shen. (2019) Managements of giant cell tumor within the distal radius: A retrospective study of 58 cases from a single center. Journal of Bone Oncology 14, pages 100211.
Crossref
Crossref
Ziyad M Mohaidat, Hisham Z Al-jamal, Audai M Bany-Khalaf, Ahmad M Radaideh & Ziad A Audat. (2019) Giant cell tumor of bone: Unusual features of a rare tumor. Rare Tumors 11, pages 203636131987889.
Crossref
Crossref
M. R. MedellinT. FujiwaraR. M. TillmanL. M. JeysJ. GregoryJ. D. StevensonM. ParryA. Abudu. (2018) Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture. The Bone & Joint Journal 100-B:12, pages 1626-1632.
Crossref
Crossref
Abhijeet Ashok Salunke, Subodh Pathak, Jaymin Shah, Jyotindra Pandit & Vinod Naneria. (2018) Wide resection versus curettage in giant cell tumor with pathological fracture? A systematic review and meta-analysis. Journal of Clinical Orthopaedics and Trauma 9, pages S15-S18.
Crossref
Crossref
Arvind Kumar & Usha Singh. (2017) GIANT CELL TUMOUR WITH VARIED PRESENTATION. Journal of Evidence Based Medicine and Healthcare 4:40, pages 2397-2401.
Crossref
Crossref
Lizz van der Heijden, P.D. Sander Dijkstra, Jean-Yves Blay & Hans Gelderblom. (2017) Giant cell tumour of bone in the denosumab era. European Journal of Cancer 77, pages 75-83.
Crossref
Crossref
Andreas F. Mavrogenis, Vasileios G. Igoumenou, Panayiotis D. Megaloikonomos, Georgios N. Panagopoulos, Panayiotis J. Papagelopoulos & Panayotis N. Soucacos. (2017) Giant cell tumor of bone revisited. SICOT-J 3, pages 54.
Crossref
Crossref
Dongqi Li, Jinlei Zhang, Yi Li, Junfeng Xia, Yihao Yang, Mingyan Ren, Yedan Liao, Shunling Yu, Xiaojuan Li, Yan Shen, Ya Zhang & Zuozhang Yang. (2016) Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Justyna M. Amelio, Julia Rockberg, Rohini K. Hernandez, Patrik Sobocki, Scott Stryker, Bruce A. Bach, Jacob Engellau & Alexander Liede. (2016) Population-based study of giant cell tumor of bone in Sweden (1983–2011). Cancer Epidemiology 42, pages 82-89.
Crossref
Crossref
A. A. SalunkeY. ChenX. ChenJ. H. TanG. SinghB. C. TaiL. W. KhinM. E. Puhaindran. (2015) Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone?. The Bone & Joint Journal 97-B:11, pages 1566-1571.
Crossref
Crossref
Helcio Mendonça Pereira, Edson Marchiori & Alessandro Severo. (2014) Magnetic resonance imaging aspects of giant-cell tumours of bone. Journal of Medical Imaging and Radiation Oncology 58:6, pages 674-678.
Crossref
Crossref
Maximilian Martinez, John Hwang & Kathleen S. Beebe. (2014) Local adjuvants for benign aggressive bone tumors. Current Orthopaedic Practice 25:6, pages 573-579.
Crossref
Crossref
Liang Chen, Xiao-Yi Ding, Chengs-Sheng Wang, Ming-Jue Si, Lian-Jun Du, Wei-Bin Zhang & Yong Lu. (2014) In-depth analysis of local recurrence of giant cell tumour of bone with soft tissue extension after intralesional curettage. La radiologia medica 119:11, pages 861-870.
Crossref
Crossref
L. van der Heijden, M. A. J. van de Sande, I. C. M. van der Geest, H. W. B. Schreuder, B. J. van Royen, P. C. Jutte, J. A. M. Bramer, F. C. Öner, A. P. van Noort-Suijdendorp, H. M. Kroon & P. D. S. Dijkstra. (2014) Giant cell tumors of the sacrum—a nationwide study on midterm results in 26 patients after intralesional excision. European Spine Journal 23:9, pages 1949-1962.
Crossref
Crossref
Lizz van der Heijden, P.D. Sander Dijkstra, Michiel A.J. van de Sande, Judith R. Kroep, Remi A. Nout, Carla S.P. van Rijswijk, Judith V.M.G. Bovée, Pancras C.W. Hogendoorn & Hans Gelderblom. (2014) The Clinical Approach Toward Giant Cell Tumor of Bone. The Oncologist 19:5, pages 550-561.
Crossref
Crossref
Lizz van der Heijden, Ingrid C.M. van der Geest, H.W. Bart Schreuder, Michiel A.J. van de Sande & P.D. Sander Dijkstra. (2014) Liquid Nitrogen or Phenolization for Giant Cell Tumor of Bone?. Journal of Bone and Joint Surgery 96:5, pages e35.
Crossref
Crossref
Dongqing Zuo, Longpo Zheng, Wei Sun, Dong Fu, Yingqi Hua & Zhengdong Cai. (2013) Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis. World Journal of Surgical Oncology 11:1.
Crossref
Crossref
Lizz van der Heijden, Michiel A.J. van de Sande, Adriaan C. Heineken, Marta Fiocco, Rob G.H.H. Nelissen & P.D. Sander Dijkstra. (2013) Mid-Term Outcome After Curettage with Polymethylmethacrylate for Giant Cell Tumor Around the Knee: Higher Risk of Radiographic Osteoarthritis?. Journal of Bone and Joint Surgery 95:21, pages e159.
Crossref
Crossref
V. C. OliveiraL. van der HeijdenI. C. M. van der GeestD. A. CampanacciC. L. M. H. GibbonsM. A. J. van de SandeP. D. S. Dijkstra. (2013) Giant cell tumours of the small bones of the hands and feet. The Bone & Joint Journal 95-B:6, pages 838-845.
Crossref
Crossref